Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Treasury Shares (2024 - 2025)

Janux Therapeutics (JANX) has disclosed Treasury Shares for 2 consecutive years, with $704869.0 as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares rose 106.19% to $704869.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $704869.0, a 106.19% increase, with the full-year FY2025 number at $704869.0, up 106.19% from a year prior.
  • Treasury Shares was $704869.0 for Q4 2025 at Janux Therapeutics, up from $699467.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $704869.0 in Q4 2025 to a low of $17500.0 in Q2 2024.